Close Menu

NEW YORK (GenomeWeb) – During the Ebola crisis that swept through West Africa in 2014 and is ongoing in certain countries, efforts at dealing with the virus that has killed more than 8,000 people on the continent have been hindered by an inability to differentially diagnose Ebola from other similar ailments. 

Now, though, Genalyte has developed a test that it says can tell whether a patient has Ebola or one of a number of other similar diseases, including hemorrhagic fevers, with a single drop of whole blood in about 10 minutes. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.